Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared continuous fluconazole therapy to periodic therapy in HIV-positive patients with recurrent oral candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Candidiasis, Oral, HIV Infections | Phase 4 | Status: COMPLETED